Relapses do not matter in relation to long-term disability: Commentary

Multiple Sclerosis Journal

Volumn 17, Issue 12, 2011, Pages 1417-

  Hutchinson, Michael ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

CEREBROSPINAL FLUID; DISABILITY; DISEASE COURSE; HUMAN; INFLAMMATORY DISEASE; MULTIPLE SCLEROSIS; NEUROFILAMENT; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RELAPSE; TREATMENT PLANNING;

EID: 82555176754     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511427512     Document Type: Note

References (7)

1. Thompson AJ, Miller D, Youl B, MacManus D, Moore S, Kingsley D, et al. Serial gadolinium-enhanced MRI in relapsing/ remitting multiple sclerosis of varying disease duration. Neurology. 1992 ; 42: 60-63
2. Cadavid D, Wolansky LJ, Skurnick J, Lincoln J, Cheriyan J, Szczepanowski K, et al. Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study. Neurology. 2009 ; 72: 1976-1983
3. Bagnato F, Jeffries N, Richert ND, Stone RD, Ohayon JM, McFarland HF, et al. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain. 2003 ; 126: 1782-1789 (Pubitemid 36917337)
4. Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, Gentleman SM, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain. 2011 ;:
5. Scalfari A, Neuhaus A, Degenhardt A, Rice GP, Muraro PA, Daumer M, et al Brain. 2010: 1914-1929.
6. Giovannoni G, Nath A. After the storm: neurofilament levels as a surrogate endpoint for neuroaxonal damage. Neurology. 2011 ; 76: 1200-1201
7. Scalfari A, Neuhaus A, Daumer M, Ebers GC, Muraro PA. Age and disability accumulation in multiple sclerosis. Neurology. 2011 ; 77: 1246-1252